vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Rimini Street, Inc. (RMNI). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $105.5M, roughly 1.6× Rimini Street, Inc.). Rimini Street, Inc. runs the higher net margin — 1.3% vs -82.0%, a 83.2% gap on every dollar of revenue. On growth, Rimini Street, Inc. posted the faster year-over-year revenue change (1.2% vs -22.7%). Over the past eight quarters, Rimini Street, Inc.'s revenue compounded faster (1.1% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Rimini Street, Inc. is a global provider of independent third-party support services for enterprise software products including Oracle and SAP platforms. It serves clients across multiple industries worldwide, delivering cost-effective support, maintenance, and consulting solutions that help businesses cut operational expenses while ensuring software performance and security.
PTCT vs RMNI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $105.5M |
| Net Profit | $-135.0M | $1.4M |
| Gross Margin | — | 59.0% |
| Operating Margin | -43.3% | 4.6% |
| Net Margin | -82.0% | 1.3% |
| Revenue YoY | -22.7% | 1.2% |
| Net Profit YoY | -104.8% | -59.4% |
| EPS (diluted) | $-1.63 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $105.5M | ||
| Q4 25 | $164.7M | $109.8M | ||
| Q3 25 | $211.0M | $103.4M | ||
| Q2 25 | $178.9M | $104.1M | ||
| Q1 25 | $1.2B | $104.2M | ||
| Q4 24 | $213.2M | $114.2M | ||
| Q3 24 | $196.8M | $104.7M | ||
| Q2 24 | $186.7M | $103.1M |
| Q1 26 | — | $1.4M | ||
| Q4 25 | $-135.0M | $724.0K | ||
| Q3 25 | $15.9M | $2.8M | ||
| Q2 25 | $-64.8M | $30.3M | ||
| Q1 25 | $866.6M | $3.4M | ||
| Q4 24 | $-65.9M | $6.7M | ||
| Q3 24 | $-106.7M | $-43.1M | ||
| Q2 24 | $-99.2M | $-1.1M |
| Q1 26 | — | 59.0% | ||
| Q4 25 | — | 60.4% | ||
| Q3 25 | — | 59.9% | ||
| Q2 25 | — | 60.4% | ||
| Q1 25 | — | 61.0% | ||
| Q4 24 | — | 63.7% | ||
| Q3 24 | — | 60.7% | ||
| Q2 24 | — | 59.1% |
| Q1 26 | — | 4.6% | ||
| Q4 25 | -43.3% | 4.5% | ||
| Q3 25 | 1.4% | 4.2% | ||
| Q2 25 | -19.5% | 39.6% | ||
| Q1 25 | 82.5% | 9.0% | ||
| Q4 24 | -76.2% | 13.0% | ||
| Q3 24 | -27.7% | -47.4% | ||
| Q2 24 | -21.5% | -0.8% |
| Q1 26 | — | 1.3% | ||
| Q4 25 | -82.0% | 0.7% | ||
| Q3 25 | 7.5% | 2.7% | ||
| Q2 25 | -36.3% | 29.1% | ||
| Q1 25 | 73.7% | 3.2% | ||
| Q4 24 | -30.9% | 5.8% | ||
| Q3 24 | -54.2% | -41.2% | ||
| Q2 24 | -53.1% | -1.1% |
| Q1 26 | — | $0.01 | ||
| Q4 25 | $-1.63 | $0.00 | ||
| Q3 25 | $0.20 | $0.03 | ||
| Q2 25 | $-0.83 | $0.32 | ||
| Q1 25 | $10.04 | $0.04 | ||
| Q4 24 | $-0.85 | $0.07 | ||
| Q3 24 | $-1.39 | $-0.47 | ||
| Q2 24 | $-1.29 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $132.2M |
| Total DebtLower is stronger | — | $56.4M |
| Stockholders' EquityBook value | $-205.3M | — |
| Total Assets | $2.9B | $397.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $132.2M | ||
| Q4 25 | $1.9B | $120.0M | ||
| Q3 25 | $1.7B | $108.7M | ||
| Q2 25 | $2.0B | $101.3M | ||
| Q1 25 | $2.0B | $122.6M | ||
| Q4 24 | $1.1B | $88.8M | ||
| Q3 24 | $1.0B | $119.5M | ||
| Q2 24 | $1.1B | $134.2M |
| Q1 26 | — | $56.4M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $-205.3M | $-27.0M | ||
| Q3 25 | $-155.8M | $-27.3M | ||
| Q2 25 | $-206.5M | $-29.0M | ||
| Q1 25 | $-185.8M | $-63.7M | ||
| Q4 24 | $-1.1B | $-69.4M | ||
| Q3 24 | $-1.1B | $-76.8M | ||
| Q2 24 | $-980.2M | $-36.1M |
| Q1 26 | — | $397.1M | ||
| Q4 25 | $2.9B | $423.1M | ||
| Q3 25 | $2.6B | $352.9M | ||
| Q2 25 | $2.6B | $397.5M | ||
| Q1 25 | $2.7B | $343.0M | ||
| Q4 24 | $1.7B | $369.1M | ||
| Q3 24 | $1.8B | $343.8M | ||
| Q2 24 | $1.9B | $367.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | — |
| Free Cash FlowOCF − Capex | $-36.6M | — |
| FCF MarginFCF / Revenue | -22.3% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.3M | $19.6M | ||
| Q3 25 | $-66.3M | $24.7M | ||
| Q2 25 | $-58.3M | $-17.8M | ||
| Q1 25 | $870.1M | $33.7M | ||
| Q4 24 | $-30.0M | $-37.7M | ||
| Q3 24 | $-77.0M | $-18.5M | ||
| Q2 24 | $-71.5M | $6.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-36.6M | $18.9M | ||
| Q3 25 | $-69.7M | $23.5M | ||
| Q2 25 | $-59.6M | $-19.5M | ||
| Q1 25 | $868.4M | $32.8M | ||
| Q4 24 | $-33.8M | $-38.4M | ||
| Q3 24 | $-77.5M | $-19.2M | ||
| Q2 24 | $-78.8M | $5.4M |
| Q1 26 | — | — | ||
| Q4 25 | -22.3% | 17.2% | ||
| Q3 25 | -33.1% | 22.7% | ||
| Q2 25 | -33.3% | -18.8% | ||
| Q1 25 | 73.8% | 31.5% | ||
| Q4 24 | -15.8% | -33.6% | ||
| Q3 24 | -39.4% | -18.3% | ||
| Q2 24 | -42.2% | 5.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 0.6% | ||
| Q3 25 | 1.6% | 1.2% | ||
| Q2 25 | 0.7% | 1.7% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 1.8% | 0.6% | ||
| Q3 24 | 0.3% | 0.6% | ||
| Q2 24 | 4.0% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.02× | ||
| Q3 25 | -4.17× | 8.94× | ||
| Q2 25 | — | -0.59× | ||
| Q1 25 | 1.00× | 10.06× | ||
| Q4 24 | — | -5.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
